Companies House 15790563 2025-06-30 2025-06-30 2024-06-20 false iso4217:GBP xbrli:pure 15790563 2025-06-30 15790563 2024-06-20 2025-06-30 15790563 curr:PoundSterling 2024-06-20 2025-06-30 15790563 uk-bus:CompanyLimitedByGuarantee 2024-06-20 2025-06-30 15790563 uk-bus:FRS102 2024-06-20 2025-06-30 15790563 uk-bus:AuditExempt-NoAccountantsReport 2024-06-20 2025-06-30 15790563 uk-bus:FullAccounts 2024-06-20 2025-06-30 15790563 uk-bus:RegisteredOffice 2024-06-20 2025-06-30 15790563 uk-bus:Director1 2024-06-20 2025-06-30 15790563 uk-bus:Director2 2024-06-20 2025-06-30 15790563 uk-bus:Director3 2024-06-20 2025-06-30 15790563 uk-bus:Director4 2024-06-20 2025-06-30 15790563 uk-bus:Director5 2024-06-20 2025-06-30 15790563 uk-bus:Director6 2024-06-20 2025-06-30 15790563 uk-bus:Director7 2024-06-20 2025-06-30 15790563 uk-bus:Director8 2024-06-20 2025-06-30 15790563 uk-bus:Director9 2024-06-20 2025-06-30 15790563 uk-bus:Director10 2024-06-20 2025-06-30 15790563 uk-bus:Director11 2024-06-20 2025-06-30 15790563 uk-bus:Director12 2024-06-20 2025-06-30 15790563 uk-bus:Director13 2024-06-20 2025-06-30 15790563 uk-bus:Director14 2024-06-20 2025-06-30 15790563 uk-bus:Director15 2024-06-20 2025-06-30 15790563 uk-bus:Director16 2024-06-20 2025-06-30 15790563 uk-bus:Director17 2024-06-20 2025-06-30 15790563 uk-bus:Director18 2024-06-20 2025-06-30 15790563 uk-bus:Director19 2024-06-20 2025-06-30 15790563 uk-bus:Director20 2024-06-20 2025-06-30 15790563 uk-bus:Director21 2024-06-20 2025-06-30 15790563 uk-bus:CompanySecretary1 2024-06-20 2025-06-30 15790563 core:AfterOneYear 2025-06-30 15790563 core:WithinOneYear 2025-06-30 15790563 core:WithinOneYear 2024-06-20 2025-06-30 15790563 core:AfterOneYear 2025-06-30 15790563 core:AfterOneYear 2024-06-20 2025-06-30 15790563 core:ShareCapital 2025-06-30 15790563 core:SharePremium 2025-06-30 15790563 core:OtherReservesSubtotal 2025-06-30 15790563 core:RevaluationReserve 2025-06-30 15790563 core:RetainedEarningsAccumulatedLosses 2025-06-30 15790563 1 2024-06-20 2025-06-30 15790563 2 2024-06-20 2025-06-30 15790563 3 2024-06-20 2025-06-30 15790563 core:LandBuildings 2024-06-20 2025-06-30 15790563 core:LandBuildings 2025-06-30 15790563 core:PlantMachinery 2024-06-20 2025-06-30 15790563 core:PlantMachinery 2025-06-30 15790563 core:FurnitureFittingsToolsEquipment 2024-06-20 2025-06-30 15790563 core:FurnitureFittingsToolsEquipment 2025-06-30 15790563 core:OfficeEquipment 2024-06-20 2025-06-30 15790563 core:OfficeEquipment 2025-06-30 15790563 core:Vehicles 2024-06-20 2025-06-30 15790563 core:Vehicles 2025-06-30 15790563 core:NetGoodwill 2024-06-20 2025-06-30 15790563 core:NetGoodwill 2025-06-30 15790563 core:IntangibleAssetsOtherThanGoodwill 2024-06-20 2025-06-30 15790563 core:IntangibleAssetsOtherThanGoodwill 2025-06-30

# NEUROCONVERSE LTD

## Company limited by guarantee

## Company Registration Number:
15790563 (England and Wales)

## Unaudited statutory accounts for the year ended 30 June 2025

## Period of accounts

## Start date: 20 June 2024

## End date: 30 June 2025

# NEUROCONVERSE LTD

## Contents of the Financial Statements

for the Period Ended 30 June 2025

Profit and loss |
Balance sheet |
Additional notes |

# NEUROCONVERSE LTD

## Profit And Loss Account

for the Period Ended 30 June 2025

| 2025
--- | ---
| £
Turnover: | 0 |
Cost of sales: | 0 |
Gross profit(or loss): | 0
Distribution costs: | 0 |
Administrative expenses: | ( 517 ) |
Other operating income: | 0 |
Operating profit(or loss): | (517)
Interest receivable and similar income: | 0 |
Interest payable and similar charges: | 0 |
Profit(or loss) before tax: | (517)
Tax: | 0 |
Profit(or loss) for the financial year: | (517)

# NEUROCONVERSE LTD

## Balance sheet

As at 30 June 2025

| Notes | 2025
--- | --- | ---
|  | £
Fixed assets
Intangible assets: |  | 0 |
Tangible assets: |  | 0 |
Investments: |  | 0 |
Total fixed assets: |  | 0
Current assets
Stocks: |  | 0 |
Debtors: |  | 0 |
Cash at bank and in hand: |  | 0 |
Investments: |  | 0 |
Total current assets: |  | 0
Prepayments and accrued income: |  | 0 |
Creditors: amounts falling due within one year: |  | 0 |
Net current assets (liabilities): |  | 0
Total assets less current liabilities: |  | 0
Creditors: amounts falling due after more than one year: |  | 0 |
Provision for liabilities: |  | 0 |
Accruals and deferred income: |  | 0 |
Total net assets (liabilities): |  | 0
Members' funds
Profit and loss account: |  | 0 |
Total members' funds: |  | 0

The notes form part of these financial statements

# NEUROCONVERSE LTD

## Balance sheet statements

For the year ending 30 June 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 12 March 2026
and signed on behalf of the board by:

Name: Martin Bloomfield
Status: Director

The notes form part of these financial statements

# NEUROCONVERSE LTD

## Notes to the Financial Statements

for the Period Ended 30 June 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# NEUROCONVERSE LTD

## Notes to the Financial Statements

for the Period Ended 30 June 2025

- ## 2. Employees

  | 2025
  --- | ---
  Average number of employees during the period | 0 |